The number of drug-resistant tuberculosis (TB) cases is rising globally. But a newly discovered natural antibiotic — produced by bacteria from the lung infection in a cystic fibrosis patient — could help fight these infections.
Lab testing reported in the Journal of the American Chemical Society shows that the compound is active against multi-drug resistant strains.
Starting with the famous first discovery of penicillin from mold, scientists have continued to search for natural sources of antibiotics. And as pathogens develop resistance to once-reliable medicines, the search has taken on a new urgency. By 2040, more than a third of all TB cases in Russia, for example, could show resistance to first-line drugs currently used to fight the disease, a recent report published in Lancet estimates. Among potential new drug sources are species of the bacterial genus Burkholderia that thrive in a wide range of habitats, from soil to the human lung. One way these microbes have adapted to these diverse environments is by making potent antibiotics to take out their competition. In light of the growing threat of drug-resistant bacteria, particularly among TB strains, Gregory L. Challis, Eshwar Mahenthiralingam and colleagues wanted to see if Burkholderia might produce a promising anti-TB compound.
The researchers discovered that one species, Burkholderia gladioli, which was isolated from the sputum of a child with cystic fibrosis, produces an antibiotic called gladiolin. The compound belongs to the same structural class as etnangien, another antibiotic that has been investigated for its ability to jam bacterial cell machinery. But etnangien is highly unstable. The researchers found that gladiolin is much more stable than etnangien, and could therefore potentially be a better drug candidate. Lab testing also showed that gladiolin blocked the growth of four drug-resistant TB strains.
Learn more: Bacteria from cystic fibrosis patient could help thwart antibiotic-resistant TB
[osd_subscribe categories=’tuberculosis’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “TUBERCULOSIS”‘]
The Latest on: Antibiotic-resistant TB
[google_news title=”” keyword=”antibiotic-resistant TB” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Sketchy stem-cell treatments in Mexico led to drug-resistant infectionson May 13, 2024 at 2:26 pm
Three U.S. hospital patients contracted drug-resistant infections in Mexico in 2022 and were still being treated as of March 2024.
- Alarming Levels of Antibiotic Resistance Found in the Poultry Environmenton May 9, 2024 at 2:28 am
NewsVoir New Delhi [India] May 9 This World Poultry Day brings in a new study highlighting alarming levels of Resistance Genes against medically important antibiotics in the Poultry Environment A coll ...
- BioVersys expands collaboration with GSK to speed up development of alpibectir for treatment of tuberculosison May 8, 2024 at 12:30 am
BioVersys expands collaboration with GSK to speed up development of alpibectir for treatment of tuberculosis: Basel, Switzerland Wednesday, May 8, 2024, 13:00 Hrs [IST] BioVersys ...
- Fred Allendorf: Science and Nature: Evolution of antibiotic resistance in bacteriaon May 7, 2024 at 5:45 am
Approximately 8 million people die annually around the world from infectious diseases caused by bacteria. Bacterial diseases have been the major cause of human mortality throughout history. For ...
- GSK commits to further support of BioVersys’ TB drugon May 7, 2024 at 4:01 am
Alpibectir was developed in a public-private collaboration between GSK, Pasteur Institute Lille, and the University of Lille, and is designed as a companion to ethionamide (Eto), which is an important ...
- Public Health: 2 new drug-resistant TB cases on Guam, 3rd person being treated for relapseon May 5, 2024 at 10:55 pm
The Department of Public Health and Social Services has identified two new multidrug-resistant tuberculosis cases, while a third person on Guam is being treated for a relapse of the disease.
- Experts developing immune-enhancing therapies to treat TB: Studyon May 2, 2024 at 8:15 am
Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body's immune system to target TB, to tackle even drug-resistant strains of the ...
- The harsh reality of multidrug resistant TB in childrenon May 2, 2024 at 2:25 am
Only about 12%-16% of children and young adolescents with MDR-TB or rifampicin-resistant TB were diagnosed and treated in 2022. Diagnosing them is hard, and the treatment course is lengthy and ...
- With pandemic over, deadliest infectious disease in world is still tuberculosison May 1, 2024 at 3:02 am
Just a short time after “Gone With the Wind star” Vivien Leigh appeared at Atlanta’s Loews Grand Theatre for the 1939 premiere of the legendary film, the British actress caught tuberculosis on a trip ...
- Immune-enhancing therapies to treat TB: Studyon May 1, 2024 at 1:06 am
Experts are developing revolutionary immune-enhancing medicines known as host-directed therapies, which employ the body's immune system to target TB, to tackle even drug -resistant strains of the ...
via Google News and Bing News